» Articles » PMID: 22071954

The Clinical Value of Single Photon Emission Computed Tomography Myocardial Perfusion Imaging in Cardiac Risk Stratification of Very Elderly Patients (≥80 Years) with Suspected Coronary Artery Disease

Overview
Journal J Nucl Cardiol
Date 2011 Nov 11
PMID 22071954
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The role of single photon emission computed tomography myocardial perfusion imaging (SPECT MPI) in cardiac evaluation of the very elderly patients is unclear. We investigated the clinical value of SPECT MPI in very elderly patients (≥80 years) with suspected coronary artery disease (CAD) as well as in comparison to younger patients.

Methods And Results: A retrospective analysis of prospectively collected data from 8,864 patients [1,093 patients ≥80 years (very elderly), 3,369 patients 65-79 years (elderly), and 4,402 patients 50-64 years (middle-aged)] with suspected CAD who underwent exercise and/or pharmacologic stress testing with SPECT MPI between 1996 and 2005 was performed. Clinical and SPECT MPI characteristics, cardiac event rates, early (≤60 days) cardiac catheterization and revascularization rates of very elderly patients were compared to that of younger patients. Mean follow-up for cardiac events (cardiac death or non-fatal myocardial infarction) was 1.9 ± 0.9 years. Very elderly patients with moderate to severely abnormal SSS had a significantly higher annualized cardiac event rate than those with mildly abnormal or normal study (9.6% vs 3.4% and 2.5% respectively, P < .001). Across all categories of SSS, very elderly patients had a significantly higher cardiac event rate as compared to younger patients (P < .001). Early cardiac catheterization and revascularization referrals in very elderly patients increased as a function of severity of ischemia on SPECT MPI (P < .001), although these referral rates were significantly lower in very elderly patients with mild to moderate and severe ischemia as compared to younger patients (P < .05).

Conclusions: In very elderly patients (≥80 years) with suspected CAD, SPECT MPI has prognostic and incremental value in the noninvasive cardiovascular assessment for risk stratification and may influence medical decisions.

Citing Articles

Impact of cardiac size on diagnostic performance of single-photon emission computed tomography myocardial perfusion imaging: insights from the REgistry of Fast Myocardial Perfusion Imaging with NExt generation single-photon emission computed....

Randazzo M, Elias P, Poterucha T, Sharir T, Fish M, Ruddy T Eur Heart J Cardiovasc Imaging. 2024; 25(7):996-1006.

PMID: 38445511 PMC: 11210974. DOI: 10.1093/ehjci/jeae055.


Cardiovascular outcomes and mortality after abnormal myocardial perfusion scans in the elderly: a retrospective study at a tertiary care institution.

Gupta S, Sheth S, Kamisetty S, Foreman M, Winchester D J Geriatr Cardiol. 2023; 20(10):760-761.

PMID: 37970229 PMC: 10630167. DOI: 10.26599/1671-5411.2023.10.008.


Cardiovascular Biomarkers and Imaging in Older Adults: JACC Council Perspectives.

Forman D, de Lemos J, Shaw L, Reuben D, Lyubarova R, Peterson E J Am Coll Cardiol. 2020; 76(13):1577-1594.

PMID: 32972536 PMC: 7540920. DOI: 10.1016/j.jacc.2020.07.055.


Update of the Brazilian Guideline on Nuclear Cardiology - 2020.

Mastrocola L, Amorim B, Vitola J, Brandao S, Grossman G, Lima R Arq Bras Cardiol. 2020; 114(2):325-429.

PMID: 32215507 PMC: 7077582. DOI: 10.36660/abc.20200087.


Association between abnormal myocardial scintigraphy findings and long-term outcomes for elderly patients 85 years or older: a retrospective cohort study.

Kato T, Okano M, Haruna Y, Inoko M BMC Cardiovasc Disord. 2019; 19(1):246.

PMID: 31694562 PMC: 6833266. DOI: 10.1186/s12872-019-1240-y.


References
1.
Henzlova M, Cerqueira M, Mahmarian J, Yao S . Stress protocols and tracers. J Nucl Cardiol. 2006; 13(6):e80-90. DOI: 10.1016/j.nuclcard.2006.08.011. View

2.
McClellan J, Travin M, Herman S, Baron J, Golub R, Gallagher J . Prognostic importance of scintigraphic left ventricular cavity dilation during intravenous dipyridamole technetium-99m sestamibi myocardial tomographic imaging in predicting coronary events. Am J Cardiol. 1997; 79(5):600-5. DOI: 10.1016/s0002-9149(96)00823-5. View

3.
Stratmann H, Williams G, Wittry M, Chaitman B, Miller D . Exercise technetium-99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain. Circulation. 1994; 89(2):615-22. DOI: 10.1161/01.cir.89.2.615. View

4.
Klocke F, Baird M, Lorell B, Bateman T, Messer J, Berman D . ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995.... Circulation. 2003; 108(11):1404-18. DOI: 10.1161/01.CIR.0000080946.42225.4D. View

5.
Mathur S, Shah A, Ahlberg A, Katten D, Heller G . Blunted heart rate response as a predictor of cardiac death in patients undergoing vasodilator stress technetium-99m sestamibi gated SPECT myocardial perfusion imaging. J Nucl Cardiol. 2010; 17(4):617-24. DOI: 10.1007/s12350-010-9242-2. View